Ethyl Benzoate

Ethyl Benzoate

SCHEMBL9345283

CCOC(=O)c1ccccc1.[NaH]

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.68
SMN1; SMN2 Q16637 4/20 0.67
RAB9A P51151 3/20 0.67
NPC1 O15118 2/20 0.67
GAA P10253 2/20 0.67
KMT2A Q03164 4/20 0.66
MEN1 O00255 3/20 0.66
CA12 O43570 1/20 0.64
CA1 P00915 1/20 0.64
CA2 P00918 1/20 0.64
ESR1 P03372 1/20 0.64
CA7 P43166 1/20 0.64
CA9 Q16790 1/20 0.64
ESR2 Q92731 1/20 0.64
CA14 Q9ULX7 1/20 0.64
TSHR P16473 3/20 0.63
CYP1A2 P05177 1/20 0.62
CYP3A4 P08684 1/20 0.62
MAOA P21397 1/20 0.62
TDP1 Q9NUW8 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Benzoate SCHEMBL25388294 0.98 LMNA (0.70) LMNASMN1; SMN2RAB9ANPC1GAA
Ethyl Benzoate SCHEMBL2762273 0.98 LMNA (0.70) LMNASMN1; SMN2RAB9ANPC1GAA
Ethyl Benzoate SCHEMBL55674 0.98 LMNA (0.70) LMNASMN1; SMN2RAB9ANPC1GAA
Ethyl Benzoate SCHEMBL28365249 0.96 LMNA (0.68) LMNASMN1; SMN2RAB9ANPC1GAA
Ethyl Benzoate SCHEMBL1404143 0.96 LMNA (0.68) LMNASMN1; SMN2RAB9ANPC1GAA
Ethyl Benzoate SCHEMBL30886688 0.96 LMNA (0.68) LMNASMN1; SMN2RAB9ANPC1GAA
Ethyl Benzoate SCHEMBL29554608 0.96 LMNA (0.68) LMNASMN1; SMN2RAB9ANPC1GAA
Ethyl Benzoate SCHEMBL595705 0.96 LMNA (0.68) LMNASMN1; SMN2RAB9ANPC1GAA
Ethyl Benzoate SCHEMBL10340677 0.96 LMNA (0.68) LMNASMN1; SMN2RAB9ANPC1GAA
Ethyl Benzoate SCHEMBL28871046 0.96 LMNA (0.68) LMNASMN1; SMN2RAB9ANPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119874245-A Functional material capable of resisting corrosion of high-concentration composite salt for concrete 新疆水利水电勘测设计研究院有限责任公司 2025-04-25 CN claimed
CN-115400123-B Tizanidine liquid preparation and application thereof 四川科瑞德制药股份有限公司 2025-04-11 CN claimed
CN-118078716-A Liquid antibacterial composition containing trollius chinensis bunge extract and application thereof 华南理工大学 2024-05-28 CN claimed
CN-117982446-A Two-component composition 阿萨德股份有限公司 2024-05-07 CN claimed
CN-117180186-A Ebastine oral solution and preparation method thereof 北京万全德众医药生物技术有限公司 2023-12-08 CN claimed
CN-108379138-A A kind of flavorants and preparation method thereof containing vine tea flavone extract 广东工业大学 2018-08-10 CN claimed
CN-106065322-A A multiple effect of automobile non freezing solution 西安昕罗新能源科技有限公司 2016-11-02 CN claimed
CN-120983376-B Clofazimine soft capsule and preparation method thereof SHANXI LIYE PHARMACEUTICAL Co.,Ltd. (CN) 2026-05-26 CN disclosed
CN-119923247-A Compositions with improved SPF and UVA photoprotection 西姆莱斯股份公司 2025-05-02 CN disclosed
CN-119874245-A Functional material capable of resisting corrosion of high-concentration composite salt for concrete 新疆水利水电勘测设计研究院有限责任公司 2025-04-25 CN disclosed
CN-115400123-B Tizanidine liquid preparation and application thereof 四川科瑞德制药股份有限公司 2025-04-11 CN disclosed
CN-119744164-A Odor and colorant stable compositions 西姆莱斯股份公司 2025-04-01 CN disclosed
CN-119604270-A Comprising an antimicrobial agent accelerator composition 西姆莱斯股份公司 2025-03-11 CN disclosed
CN-105147658-A Ferrous fumarate docusate sodium capsule BEIJING BANGNIKANGDA MEDICAL TECHNOLOGY CO LTD 2015-12-16 CN disclosed
CN-104940165-A Capsule comprising docusate sodium and dantron and preparation method of capsule BEIJING KANGYUAN PHARMACEUTICAL CO PHARMACEUTICAL CO LTD LTD 2015-09-30 CN disclosed
CN-101504373-B Liquid stabilized serum cholinesterase reagent GUILIN LANGDAO DIAGNOSIS ARTICLE CO LTD 2010-12-08 CN disclosed
CN-101504373-A Liquid stabilized serum cholinesterase reagent GUILIN LANGDAO DIAGNOSIS ARTIC (CN) 2009-08-12 CN disclosed
CN-100350903-C Medicaments for treating colics BENNETTS THE CHEMISTS PROPRIET (ZA) 2007-11-28 CN disclosed
CN-1449281-A Medicaments for treating colics BENNETTS THE CHEMISTS PROPRIET (ZA) 2003-10-15 CN disclosed
US-5300539-A Continuous high speed homogenizing a stabilizer in the forms of aqueous dispersion with thermoplastic resin granules SHELL OIL COMPANY (US) 1994-04-05 US disclosed